Endogenous Intact PTH is Suppressed during Teriparatide (rhPTH 1-34) Administration in Postmenopausal Women with Established Osteoporosis
スポンサーリンク
概要
- 論文の詳細を見る
- 2008-06-01
著者
-
Koukoulis George
Department Of Internal Medicine University Of Thessalia
-
Koukoulis George
Department Of Endocrinology University Of Thessaly School Of Medicine
-
Polyzos Stergios
Department Of Endocrinology Ippokration General Hospital
-
Anastasilakis Athanasios
Department Of Endocrinology 424 General Military Hospital
-
EFSTATHIADOU Zoe
Department of Endocrinology, Ippokration General Hospital
-
KITA Marina
Department of Endocrinology, Ippokration General Hospital
-
AVRAMIDIS Avraam
Department of Endocrinology, Hippokratio General Hospital
-
GOULIS DIMITRIOS
Unit of Reproductive Endocrinology, First Department of Obstetrics and Gynecology, Aristotle Univers
-
SLAVAKIS ARISTIDES
Department of Microbiology, Hippocration General Hospital
-
Kita Marina
Department Of Endocrinology Ippokration General Hospital
-
Efstathiadou Zoe
Department Of Endocrinology Ippokration General Hospital
-
Goulis Dimitrios
Unit Of Reproductive Endocrinology First Department Of Obstetrics And Gynecology Aristotle Universit
-
Avramidis Avraam
Department Of Endocrinology Hippokratio General Hospital
-
Slavakis Aristides
Department Of Microbiology Hippocration General Hospital
関連論文
- Scintigraphic, biochemical, and clinical response to zoledronic acid treatment in patients with Paget's disease of bone
- Endogenous Intact PTH is Suppressed during Teriparatide (rhPTH 1-34) Administration in Postmenopausal Women with Established Osteoporosis
- Sustained Clinical Inactivity and Stabilization of GH/IGF-1 Levels in an Acromegalic Patient after Discontinuation of Somatostatin Analogue Treatment
- Enhanced Tenascin Expression Correlates with Inflammation in Primary Sclerosing Cholangitis
- Normochromic normocytic anemia in a postmenopausal woman with severe osteoporosis treated with intermittent parathyroid hormone
- Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy : a meta-analysis
- Profound hypocalcemia following effective response to zoledronic acid treatment in a patient with juvenile Paget's disease
- Serum homocysteine, folate and vitamin B_12 in patients with Paget's disease of bone : the effect of zoledronic acid